Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 4, 2004, Pages 838-844

  Bachert, Claus ^a,i   Bousquet, Jean ^b   Canonica, G Walter ^c   Durham, Stephen R ^d   Klimek, Ludger ^e   Mullol, Joaquim ^f   Van Cauwenberge, Paul B ^g   Van Hammée, Geneviève ^h  

^a Ear   (Belgium)

^b University Hospital   (Switzerland)

^c World Allergy Organization   (Singapore)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e Ctr for Rhinologie and Allergologie   (Germany)

^f Ear

^g World Allergy Forum

^h UCB PHARMA   (Belgium)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

ARIA; health related quality of life; levocetirizine; long term therapy; persistent allergic rhinitis; pharmacoeconomics

Indexed keywords

LEVOCETIRIZINE;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DERMATOPHAGOIDES; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; FLU LIKE SYNDROME; GASTROENTERITIS; GRASS POLLEN; HEADACHE; HEALTH STATUS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASAL PRURITUS; NOSE CONGESTION; OCULAR PRURITUS; PHARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; RHINORRHEA; RISK ASSESSMENT; SCORING SYSTEM; SKIN SENSITIZATION; SNEEZING; SOMNOLENCE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; CETIRIZINE; CONJUNCTIVITIS, ALLERGIC; COSTS AND COST ANALYSIS; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 4944246449     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.05.070     Document Type: Article

References (29)

1. N.S. Jones The prevalence of allergic rhinosinusitis: a review J Laryngol Otol 112 1998 1019 1030
2. J.A. Bellanti, and D.B. Wallerstedt Allergic rhinitis update: epidemiology and natural history Allergy Asthma Proc 21 2000 367 370
3. J. Bousquet, P. Van Cauwenberge, N. Khaltaev, ARIA Workshop Group, and World Health Organization Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 108 2001 S147 S334
4. P. Fireman Treatment strategies designed to minimize medical complications of allergic rhinitis Am J Rhinol 11 1997 95 102
5. E.F. Juniper Impact of upper respiratory allergic diseases on quality of life J Allergy Clin Immunol 101 1998 S386 S391
6. A.K. Thompson, E. Juniper, and E.O. Meltzer Quality of life in patients with allergic rhinitis Ann Allergy Asthma Immunol 85 2000 338 347
7. A. Tripathi, and R. Patterson Impact of allergic rhinitis treatment on quality of life Pharmacoeconomics 19 2001 891 899
8. F.E.R. Simons Learning impairment and allergic rhinitis Allergy Asthma Proc 17 1996 185 189
9. P. McMenamin Costs of hay fever in the United States in 1990 Ann Allergy 73 1994 35 39
10. B. Leynaert, F. Neukirch, P. Demoly, and J. Bousquet Epidemiologic evidence for asthma and rhinitis comorbidity J Allergy Clin Immunol 106 suppl 5 2000 S201 S205
11. B. Lundback Epidemiology of rhinitis and asthma Clin Exp Allergy 28 1998 3 10
12. S.L. Spector Overview of comorbid associations of allergic rhinitis J Allergy Clin Immunol 99 1997 S773 S780
13. J. Bousquet, P. Van Cauwenberge, N. Khaltaev, and C. Bachert Allergic rhinitis and its impact on asthma: in collaboration with the World Health Organisation: executive summary of the workshop report Allergy 57 2002 841 855
14. J. Bousquet, A.M. Vignola, and P. Demoly Links between rhinitis and asthma Allergy 58 2003 691 706
15. F. Leynadier, K. Mees, C. Arendt, and M.E. Pinelli Efficacy and safety of levocetirizine in seasonal allergic rhinitis Acta Otorhinolarygol Belg 55 2001 305 312
16. G.F. Clough, P. Boutsiouki, and M.K. Church Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin Allergy 56 2001 985 988
17. J.L. Devalia, C. De Vos, F. Hanotte, and E. Baltes A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers Allergy 56 2001 50 57
18. J.M. Gandon, and H. Allain Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers Br J Clin Pharmacol 54 2002 51 58
19. J.A. Grant, J.M. Riethuisen, B. Moulaert, and C. DeVos A double-blind randomised single-dose, crossover comparison of levocetrirzine with ebastine, fexofenadine, loratadine, mizolastine and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects Ann Allergy Asthma Immunol 88 2002 190 197
20. M. Thompson, M.G. Baylock, D.W. Sexton, A. Campbell, and G.M. Walsh Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells Clin Exp Allergy 32 2002 1 6
21. B. Kremer, L. Klimek, M. Bullinger, and R. Mosges Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis? Allergy 56 2001 957 963
22. G. Majani, I. Baiardini, A. Giardini, and G.E. Senna Health-related quality of life assessment in young adults with seasonal allergic rhinitis Allergy 56 2001 313 317
23. E.F. Juniper, and G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
24. J. Bousquet Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire J Allergy Clin Immunol 98 1996 309 316
25. J.E. Ware, K.K. Snow, M. Kosinski, and M. Gandek SF-36 Health survey: manual and interpretation guide 1993 Boston New England Medical Center, The Health Institute Boston
26. E.F. Juniper, G.H. Guyatt, L.E. Griffith, and P.J. Ferrie Interpretation of rhinoconjunctivitis quality of life questionnaire data J Allergy Clin Immunol 98 1996 843 845
27. J.A. Barber, and S.G. Thompson Analysis of cost data in randomized trials: an application of the non-parametric bootstrap Stat Med 19 2000 3219 3236
28. G. Ciprandi, S. Buscaglia, G. Pesce, C. Pronzato, V. Ricca, and S. Parmiani Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy J Allergy Clin Immunol 96 1995 971 979
29. G. Ciprandi, M.A. Tosca, G. Passalacqua, and G.W. Canonica Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy Ann Allergy Asthma Immunol 87 2001 222 226